Although these unique features, together with structural and biophysical evidence that both substitutions perturb higher order assembly of KCTD15, provide strong evidence for a causal link, the identification of additional patients with KCTD15-associated frontonasal dysplasia will clearly be required to delineate the full clinical and molecular spectrum of this disorder. This evidence concerns the gene KCTD15 and frontonasal dysplasia.